摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-methoxy-7-methyl-3-(4-methylbenzyl)-2H-chromen-2-one | 1159012-11-9

中文名称
——
中文别名
——
英文名称
5-methoxy-7-methyl-3-(4-methylbenzyl)-2H-chromen-2-one
英文别名
5-methoxy-7-methyl-3-[(4-methylphenyl)methyl]chromen-2-one
5-methoxy-7-methyl-3-(4-methylbenzyl)-2H-chromen-2-one化学式
CAS
1159012-11-9
化学式
C19H18O3
mdl
——
分子量
294.35
InChiKey
BYYVCBDELDRXCQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.5
  • 重原子数:
    22
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.21
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5-methoxy-7-methyl-3-(4-methylbenzyl)-2H-chromen-2-one三溴化硼 作用下, 以 二氯甲烷 为溶剂, 反应 24.5h, 以99%的产率得到5-Hydroxy-7-methyl-3-[(4-methylphenyl)methyl]chromen-2-one
    参考文献:
    名称:
    7-Alkyl-3-benzylcoumarins: A Versatile Scaffold for the Development of Potent and Selective Cannabinoid Receptor Agonists and Antagonists
    摘要:
    A series of 7-alkyl-3-benzylcoumarins was designed, synthesized, and tested at cannabinoid CB1 and CB2 receptors in radioligand binding and cAMP accumulation studies. 7-Alkyl-3-benzylcoumarins were found to constitute a versatile scaffold for obtaining potent CB receptor ligands with high potency at either CB1 or CB2 and a broad spectrum of efficacies. Fine-tuning of compound properties was achieved by small modifications of the substitution pattern. The most potent compounds of the present series include 5-methoxy-3-(2-methylbenzyl)-7-pentyl-2H-chromen-2-one (19a, PSB-SB-1201), a selective CB1 antagonist (K-i CB1 0.022 mu M), 5-methoxy-3-(2-methoxybenzyl)-7-pentyl-2H-chromen-2-one (21a, PSB-SB-1202), a dual CB1/CB2 agonist (CB1 K-i 0.032 mu M, EC50 0.056 mu M; CB2 K-i 0.049 mu M, EC50 0.014 mu M), 5-hydroxy-3-(2-hydroxybenzyl)-7-(2-methyloct-2-yl)-2H-chromen-2-one (25b, PSB-SB-1203), a dual CB1/CB2 ligand that blocks CB1 but activates CB2 receptors (CB1 K-i 0.244 mu M; CB2 K-i 0.210 mu M, EC50 0.054 mu M), and 7-(1-butylcyclopentyl)-5-hydroxy-3-(2-hydroxybenzyl)-2H-chromen-2-one (27b, PSB-SB-1204), a selective CB2 receptor agonist (CB1 K-i 1.59 mu M; CB2 K-i 0.068 mu M, EC50 0.048 mu M).
    DOI:
    10.1021/jm3008213
  • 作为产物:
    描述:
    2-羟基-6-甲氧基-4-甲基苯甲醛p-Methyl-zimtaldehydpotassium carbonate 作用下, 以 甲苯 为溶剂, 反应 24.0h, 以35%的产率得到5-methoxy-7-methyl-3-(4-methylbenzyl)-2H-chromen-2-one
    参考文献:
    名称:
    香豆素衍生物作为大麻素受体拮抗剂和反向激动剂的合成及药理评价
    摘要:
    在本研究中,我们使用取代的水杨醛和α,β-不饱和醛衍生物作为起始化合物,利用最近开发的本体化多米诺反应合成了36种香豆素和2 H-色烯衍生物。在放射性配体结合研究中,5取代的3-苄香豆素衍生物显示出对大麻素CB 1和CB 2受体的亲和力,并被确定为新的前导结构。在进一步的GTPγS结合研究中,选定的化合物显示为拮抗剂或反向激动剂。
    DOI:
    10.1016/j.bmc.2009.02.027
点击查看最新优质反应信息

文献信息

  • 7-Alkyl-3-benzylcoumarins: A Versatile Scaffold for the Development of Potent and Selective Cannabinoid Receptor Agonists and Antagonists
    作者:Viktor Rempel、Nicole Volz、Sonja Hinz、Tadeusz Karcz、Irene Meliciani、Martin Nieger、Wolfgang Wenzel、Stefan Bräse、Christa E. Müller
    DOI:10.1021/jm3008213
    日期:2012.9.27
    A series of 7-alkyl-3-benzylcoumarins was designed, synthesized, and tested at cannabinoid CB1 and CB2 receptors in radioligand binding and cAMP accumulation studies. 7-Alkyl-3-benzylcoumarins were found to constitute a versatile scaffold for obtaining potent CB receptor ligands with high potency at either CB1 or CB2 and a broad spectrum of efficacies. Fine-tuning of compound properties was achieved by small modifications of the substitution pattern. The most potent compounds of the present series include 5-methoxy-3-(2-methylbenzyl)-7-pentyl-2H-chromen-2-one (19a, PSB-SB-1201), a selective CB1 antagonist (K-i CB1 0.022 mu M), 5-methoxy-3-(2-methoxybenzyl)-7-pentyl-2H-chromen-2-one (21a, PSB-SB-1202), a dual CB1/CB2 agonist (CB1 K-i 0.032 mu M, EC50 0.056 mu M; CB2 K-i 0.049 mu M, EC50 0.014 mu M), 5-hydroxy-3-(2-hydroxybenzyl)-7-(2-methyloct-2-yl)-2H-chromen-2-one (25b, PSB-SB-1203), a dual CB1/CB2 ligand that blocks CB1 but activates CB2 receptors (CB1 K-i 0.244 mu M; CB2 K-i 0.210 mu M, EC50 0.054 mu M), and 7-(1-butylcyclopentyl)-5-hydroxy-3-(2-hydroxybenzyl)-2H-chromen-2-one (27b, PSB-SB-1204), a selective CB2 receptor agonist (CB1 K-i 1.59 mu M; CB2 K-i 0.068 mu M, EC50 0.048 mu M).
  • Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists
    作者:Andrea Behrenswerth、Nicole Volz、Jakob Toräng、Sonja Hinz、Stefan Bräse、Christa E. Müller
    DOI:10.1016/j.bmc.2009.02.027
    日期:2009.4
    In the present study we synthesized 36 coumarin and 2H-chromene derivatives applying a recently developed umpoled domino reaction using substituted salicylaldehyde and α,β-unsaturated aldehyde derivatives as starting compounds. In radioligand binding studies 5-substituted 3-benzylcoumarin derivatives showed affinity to cannabinoid CB1 and CB2 receptors and were identified as new lead structures. In
    在本研究中,我们使用取代的水杨醛和α,β-不饱和醛衍生物作为起始化合物,利用最近开发的本体化多米诺反应合成了36种香豆素和2 H-色烯衍生物。在放射性配体结合研究中,5取代的3-苄香豆素衍生物显示出对大麻素CB 1和CB 2受体的亲和力,并被确定为新的前导结构。在进一步的GTPγS结合研究中,选定的化合物显示为拮抗剂或反向激动剂。
查看更多